STEVE ANTOLINE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVE ANTOLINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVE ANTOLINE. STEVE ANTOLINE is Director in Protea Biosciences Group, Inc. ($PRGB).
Latest Insider Trading Transactions of STEVE ANTOLINE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 04 2017 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | J | 0.11 | 16,564,248 | 1,863,478 | 42,422,699 | |
| Apr 04 2017 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | J | 0.09 | 16,564,248 | 1,490,782 | 42,422,699 | |
| Apr 04 2017 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 16,564,248 | 0 | 26,325,894 | 9.8 M to 26.3 M (+169.69 %) |
| Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | A | 0.25 | 66,667 | 16,667 | 66,667 | |
| Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 165,573 | 0 | 6,319,426 | 6.2 M to 6.3 M (+2.69 %) |
| Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Grant | A | 0.00 | 100,000 | 0 | 6,153,853 | 6.1 M to 6.2 M (+1.65 %) |
| Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 244,456 | 0 | 6,053,853 | 5.8 M to 6.1 M (+4.21 %) |
| Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 193,894 | 0 | 5,809,397 | 5.6 M to 5.8 M (+3.45 %) |
| Mar 01 2016 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 363,273 | 0 | 5,615,503 | 5.3 M to 5.6 M (+6.92 %) |
| Apr 08 2015 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | J | 0.45 | 1,630,000 | 733,500 | 1,630,000 | |
| Mar 27 2015 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | J | 0.50 | 1,100,523 | 550,262 | 1,100,523 | |
| Mar 27 2015 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | J | 0.00 | 2,201,046 | 0 | 14,885,481 | 12.7 M to 14.9 M (+17.35 %) |
| Sep 29 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 75,000 | 60,000 | 7,575,847 | |
| Sep 29 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 75,000 | 60,000 | 7,575,847 | |
| Sep 08 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 175,000 | 140,000 | 7,500,847 | |
| Sep 08 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 175,000 | 140,000 | 7,500,847 | |
| Aug 25 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 150,000 | 120,000 | 7,325,847 | |
| Aug 25 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 150,000 | 120,000 | 7,325,847 | |
| Aug 05 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 65,000 | 52,000 | 7,175,847 | |
| Aug 05 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 65,000 | 52,000 | 7,175,847 | |
| Jul 10 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 300,000 | 240,000 | 7,110,847 | |
| Jul 10 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 300,000 | 240,000 | 7,110,847 | |
| Jul 10 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 50,000 | 40,000 | 6,810,847 | |
| Jul 10 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 50,000 | 40,000 | 6,810,847 | |
| Jul 10 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 200,000 | 160,000 | 6,760,847 | |
| Jul 10 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 200,000 | 160,000 | 6,760,847 | |
| Apr 07 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 400,000 | 320,000 | 7,320,405 | |
| Apr 07 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.80 | 400,000 | 320,000 | 7,320,405 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 250,000 | 275,000 | 6,160,847 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 250,000 | 275,000 | 6,160,847 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 152,750 | 114,563 | 5,910,847 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 152,750 | 114,563 | 5,910,847 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 305,500 | 152,750 | 5,758,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 305,500 | 152,750 | 5,758,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 305,500 | 152,750 | 5,452,597 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 305,500 | 152,750 | 5,452,597 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 251,667 | 125,834 | 5,752,597 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 251,667 | 125,834 | 5,752,597 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 125,833 | 94,375 | 6,002,597 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 125,833 | 94,375 | 6,002,597 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 251,667 | 125,834 | 5,876,764 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 251,667 | 125,834 | 5,876,764 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 5,625,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 5,625,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 5,325,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 5,325,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 93,750 | 103,125 | 5,075,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 93,750 | 103,125 | 5,075,097 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,000,000 | 1,100,000 | 4,981,347 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,000,000 | 1,100,000 | 4,981,347 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 1,990,684 | 995,342 | 3,981,347 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 1,990,684 | 995,342 | 3,981,347 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,493,013 | 1,642,314 | 5,731,347 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,493,013 | 1,642,314 | 5,731,347 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 150,000 | 165,000 | 4,238,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 150,000 | 165,000 | 4,238,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,100,000 | 1,210,000 | 4,088,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,100,000 | 1,210,000 | 4,088,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 2,988,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 2,988,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 2,688,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 2,688,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 200,000 | 100,000 | 2,438,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 200,000 | 100,000 | 2,438,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.25 | 25,000 | 56,250 | 2,238,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.25 | 25,000 | 56,250 | 2,238,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 2,213,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 2,213,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 6,667 | 13,334 | 1,213,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 6,667 | 13,334 | 1,213,334 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 36,667 | 73,334 | 1,206,667 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 36,667 | 73,334 | 1,206,667 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.50 | 100,000 | 150,000 | 1,170,000 | |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 305,500 | 152,750 | 4,565,232 | 4.3 M to 4.6 M (+7.17 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 305,500 | 152,750 | 4,565,232 | 4.3 M to 4.6 M (+7.17 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 251,667 | 125,834 | 4,259,732 | 4 M to 4.3 M (+6.28 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 251,667 | 125,834 | 4,259,732 | 4 M to 4.3 M (+6.28 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 1,990,684 | 995,342 | 4,008,065 | 2 M to 4 M (+98.68 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 1,990,684 | 995,342 | 4,008,065 | 2 M to 4 M (+98.68 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 200,000 | 100,000 | 2,017,381 | 1.8 M to 2 M (+11.00 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 200,000 | 100,000 | 2,017,381 | 1.8 M to 2 M (+11.00 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 2.00 | 50,000 | 100,000 | 1,817,381 | 1.8 M to 1.8 M (+2.83 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 2.00 | 50,000 | 100,000 | 1,817,381 | 1.8 M to 1.8 M (+2.83 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 13,333 | 20,000 | 1,767,381 | 1.8 M to 1.8 M (+0.76 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 13,333 | 20,000 | 1,767,381 | 1.8 M to 1.8 M (+0.76 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 73,333 | 110,000 | 1,754,048 | 1.7 M to 1.8 M (+4.36 %) |
| Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 73,333 | 110,000 | 1,754,048 | 1.7 M to 1.8 M (+4.36 %) |
Page: 1